What diseases is Seladelpar mainly used to treat?

Seladelpar (Seladelpar) is an innovative oral drug whose main mechanism is activation of PPAR-δ receptors. In recent years, it has received widespread attention in the treatment field of primary biliary cholangitis (PBC) and has gradually become a "new option" frequently mentioned in international guidelines and academic conferences. PBC is a chronic, autoimmune-related liver disease, which is mainly characterized by persistent bile duct damage, cholestasis, and gradual deterioration of liver function. As the disease progresses, patients often experience symptoms such as fatigue, itching, and elevated cholestasis indicators that disturb their quality of life.

Although ursodiol (UDCA) has been used as basic treatment, there are still some patients who do not respond well. Therefore, the demand for more targeted oral drugs is increasing. It is in this context that Srideepa comes into prominence. Research points out that the drug improves bile metabolism and regulates inflammation and fibrotic reactions through the PPAR-δ pathway, making it an important candidate drug for improving cholestasis indicators and relieving itching symptoms.

Because its target of action is different from traditional drugs, Siladepa is considered suitable for "patients with poor response to UDCA" or "patients who cannot use UDCA", and is therefore positioned as a second-line or alternative treatment option in real clinical use discussions in Europe and the United States.

In addition to its core indications PBC, there are currently some academic discussions about its potential application directions, such as the possibility of use in other cholestatic diseases, but no recommended clinical protocol has yet been formed, so the currently recognized and most important indication is still primary biliary cholangitis. It is worth noting that Siladepa is a prescription drug, and its use requires comprehensive judgment based on liver function, cholestasis indicators, previous treatment history, etc. You cannot buy it yourself or adjust the dosage at will, otherwise it may cause changes in liver enzymes or cause the treatment to fail to achieve the expected effect.

Reference materials:https://go.drugbank.com/drugs/DB12390